Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study  Jacob J. Christensen,

Slides:



Advertisements
Similar presentations
Lipoprotein Structures, Function and Metabolism (1)
Advertisements

Lipoproteins Clusters of lipids associated with proteins that serve as transport vehicles for lipids in the lymph and blood.
Aims 1.Outline the structural diversity of lipids. 2.Examine the biophysical characteristics of lipids. 3Outline the biochemical synthesis of fatty acids,
1 LIPID TRANSPORT Lipoproteins Lipids are transported in the blood as lipoproteins are soluble in water because the surface consists of polar lipids.
1 Midterm - 2 November 2015 In class 50 minutes Start 12:55 sharp 55 multiple choice questions –1 point each 1 short answer-10 points from lecture 1a until.
Lipid Compounds of Physiological Significance By Amr S. Moustafa, MD, PhD.
 Main lipids in the blood are the triglycerides and cholesterol.  Insoluble in the water.  Transport in the blood is via lipoproteins.
Lipoprotein Structure, Function, and Metabolism
Apolipoproteins.
Metabolic profiling of follicular fluid and plasma from natural cycle in vitro fertilization patients—a pilot study  Cassey McRae, M.Chem., N. Ellissa.
High-protein diets prevent steatosis and induce hepatic accumulation of monomethyl branched-chain fatty acids  Sonia C. Garcia Caraballo, Tine M. Comhair,
Milk type during mixed feeding: Contribution to serum cholesterol ester fatty acids in late infancy  Pia Salo, MD, Jorma Viikari, MD, Tapani Rönnemaa,
Adiponectin Correlation With Plasma Lipoprotein Subclasses Determined By NMR And With The Risk Of Venous Thrombosis. Fernández JA, Deguchi H, Pecheniuk.
Volume 67, Issue 1, Pages (July 2017)
William S. Harris, Michael Miller, Ann P. Tighe, Michael H
Optimal pharmacologic approach to patients with hypertriglyceridemia and low high- density lipoprotein-cholesterol: Randomized comparison of fenofibrate.
Genetic variation at chromosome 1p13
Markers of atherosclerotic development in children with familial hypercholesterolemia: A literature review  Ingunn Narverud, Kjetil Retterstøl, Per Ole.
Altered hepatic lipid status and apolipoprotein A-I metabolism in mice lacking phospholipid transfer protein  Sarah Siggins, Igor Bykov, Martin Hermansson,
TOTAL CHOLESTEROL.
Low-Density Lipoprotein Cholesterol, Non–High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients.
Altered leukocyte distribution under hypercholesterolemia: A cross-sectional study in children with familial hypercholesterolemia  Jacob J. Christensen,
Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment 
Individual omega-9 monounsaturated fatty acids and mortality—The Ludwigshafen Risk and Cardiovascular Health Study  Graciela E. Delgado, MSc, Bernhard.
Regulation of serum-induced lipid accumulation in human monocyte-derived macrophages by interferon-γ. Correlations with apolipoprotein E production, lipoprotein.
Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment 
Omega-6 polyunsaturated fatty acids prevent atherosclerosis development in LDLr-KO mice, in spite of displaying a pro-inflammatory profile similar to.
Plasma LIPOPROTEINS METABOLISM & DISORDERS Basil OM Saleh
Copyright © 2012 American Medical Association. All rights reserved.
Transport of lipids Title slide - the transport of lipids. Important because they aren’t water soluble.
LIPIDS AND LIPOPROTEINS Dr. Gamal Gabr
Biogenesis of Nascent High Density Lipoprotein Particles
Paul Durrington  Atherosclerosis Supplements 
Lipids of Physiological Significance
Volume 114, Issue 5, Pages (May 1998)
Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis  Z. Zainal,
Review of Cholesterol and Lipoproteins
Biogenesis of Nascent High Density Lipoprotein Particles
Charles R. Harper, MD, Terry A. Jacobson, MD  Mayo Clinic Proceedings 
Inhibition of Sebum Production with the Acetyl Coenzyme A Carboxylase Inhibitor Olumacostat Glasaretil  David W. Hunt, Geoffrey C. Winters, Roger W. Brownsey,
Omega-3 Fatty Acids for Cardioprotection
Charles R. Harper, MD, Terry A. Jacobson, MD  Mayo Clinic Proceedings 
Effect of evolocumab on lipoprotein particles
Correlation plot of the 26 assayed FAs ordered into major subfraction categories. Correlation plot of the 26 assayed FAs ordered into major subfraction.
عنوان دوره آموزشی: کاهش مصرف روغن و نمک
Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency  Don P. Wilson, MD, FNLA, Mark Friedman,
My Approach to the Patient With Familial Hypercholesterolemia
Apolipoprotein E-containing high-density lipoprotein (HDL) modifies the impact of cholesterol-overloaded HDL on incident coronary heart disease risk:
Effects of ethanol on lipids and atherosclerosis
Volume 92, Issue 3, Pages (September 2017)
Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: Age- and gender-specific baseline lipid values and percentiles  Jan.
Joshua A. Bell et al. JACC 2018;72:
II. assessment of dyslipidemias
بسم الله الرحمن الرحيم.
Dual Role of Circulating Angiopoietin-Like 4 (ANGPTL4) in Promoting Hypertriglyceridemia and Lowering Proteinuria in Nephrotic Syndrome  Nosratola D.
Scavenger Receptor B-1 Emerges as Anti-atherogenic Candidate
Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: Age- and gender-specific baseline lipid values and percentiles  Jan.
To B or Not to B: Is Non–High-Density Lipoprotein Cholesterol an Adequate Surrogate for Apolipoprotein B?  Carl J. Lavie, MD, Richard V. Milani, MD, James.
Volume 375, Issue 9725, Pages (May 2010)
Figure 1 The major pathways of lipid metabolism
New insights into lipid metabolism in the nephrotic syndrome
Volume 19, Issue 2, Pages (February 2014)
Pathophysiologic processes have an impact on the plasma metabolomic signature of endometriosis patients  Sara Vicente-Muñoz, Ph.D., Inmaculada Morcillo,
Yaoyu Chen, Jarod Rollins, Beverly Paigen, Xiaosong Wang 
Duality of statin action on lipoprotein subpopulations in the mixed dyslipidemia of metabolic syndrome: Quantity vs quality over time and implication.
Schematic representation of dyslipidaemia of metabolic syndrome.
Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study.
III. Treating dyslipidemias
Plasma lipid exchange. Plasma lipid exchange. In the presence of increased concentrations of VLDL in the circulation, cholesteryl ester transfer protein.
International Journal of Cardiology
Presentation transcript:

Comprehensive lipid and metabolite profiling of children with and without familial hypercholesterolemia: A cross-sectional study  Jacob J. Christensen, Stine M. Ulven, Kjetil Retterstøl, Ingunn Narverud, Martin P. Bogsrud, Tore Henriksen, Jens Bollerslev, Bente Halvorsen, Pål Aukrust, Kirsten B. Holven  Atherosclerosis  Volume 266, Pages 48-57 (November 2017) DOI: 10.1016/j.atherosclerosis.2017.09.021 Copyright © 2017 Elsevier B.V. Terms and Conditions

Fig. 1 Lipoprotein particle concentration and metabolic measures in statin treated children with FH (red symbols, n = 17) and non-statin treated children with FH (blue symbols, n = 30), compared with healthy children (black line, n = 57). Estimates on the right side of the zero-line indicate higher level in FH children, whereas estimates on the left side of the zero-line indicate lower level in FH children. Associations (beta coefficients) are log-transformed and SD-scaled, and adjusted for age and gender. Error bars represent 95% confidence intervals (95% CI). The corresponding absolute concentrations in both groups, as well as absolute and log-transformed (relative) differences between groups are shown in Supplemental Table 1, 2 and 3, respectively. Abbreviations (from top left-down, then top right-down): XXL, extremely large; XL, very large; L, large; M, medium; S, small; XS, very small; VLDL, very low-density lipoprotein; IDL, intermediate-density lipoprotein; LDL, low-density lipoprotein; P, particle concentration; Apo, apolipoprotein; C, cholesterol; Est, esterified; TG, triglycerides; HDL, high-density lipoprotein; D, mean diameter; TotPG, total phosphoglycerides; PC, phosphatidylcholine and other cholines; SM, sphingomyelins; TotCho, total cholines; TG.PG, ratio of TGs to phosphoglycerides; SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; FAw6, omega-6 FAs; LA, linoleic acid; FAw3, omega-3 FAs; TotFA, total FAs; UnSat, estimated degree of unsaturation; AcAce, acetoacetate; bOHBut, 3-hydroxybutyrate; Gp, glycoprotein acetyls (mainly a1-acid glycoprotein); Crea, creatinine; Alb, albumin; Ace, acetate; Glc, glucose; Lac, lactate; Cit, citrate; Ala, alanine; Gln, glutamine; Ile, isoleucine; Leu, leucine; Val, valine; Phe, phenylalanine; Tyr, tyrosine; His, histidine. For particles, units are mol/l; for apolipoproteins, units are g/l; for diameter, units are nm; for albumin, unit is signal area; for all other measurements, units are mmol/L. Atherosclerosis 2017 266, 48-57DOI: (10.1016/j.atherosclerosis.2017.09.021) Copyright © 2017 Elsevier B.V. Terms and Conditions

Fig. 2 Lipid content in atherogenic lipoprotein subclasses in statin treated children with FH (red symbols, n = 17) and non-statin treated children with FH (blue symbols, n = 30), compared with healthy children (black line, n = 57). Estimates on the right side of the zero-line indicate higher level in FH children, whereas estimates on the left side of the zero-line indicate lower level in FH children. Associations (beta coefficients) are log-transformed and SD-scaled, and adjusted for age and gender. Error bars represent 95% confidence intervals (95% CI). The corresponding absolute concentrations in both groups, as well as absolute and log-transformed (relative) differences between groups, are shown in Supplemental Table 1, 2 and 3, respectively. Abbreviations (from top left-down, then top right-down): XXL, extremely large; XL, very large; L, large; M, medium; S, small; XS, very small; VLDL, very low-density lipoprotein; IDL, intermediate-density lipoprotein; LDL, low-density lipoprotein; L, total lipids; P, phospholipids; C, cholesterol; CE, cholesteryl esters; FC, free cholesterol; TG, triglycerides. For all measurements, units are mmol/L. Atherosclerosis 2017 266, 48-57DOI: (10.1016/j.atherosclerosis.2017.09.021) Copyright © 2017 Elsevier B.V. Terms and Conditions

Fig. 3 Lipid content in HDL subclasses in statin treated children with FH (red symbols, n = 17) and non-statin treated children with FH (blue symbols, n = 30), compared with healthy children (black line, n = 57). Estimates on the right side of the zero-line indicate higher level in FH children, whereas estimates on the left side of the zero-line indicate lower level in FH children. Associations (beta coefficients) are log-transformed and SD-scaled, and adjusted for age and gender. Error bars represent 95% confidence intervals (95% CI). The corresponding absolute concentrations in both groups, as well as absolute and log-transformed (relative) differences between groups are shown in Supplemental Table 1, 2 and 3, respectively. Abbreviations (from top left-down, then top right-down): XL, very large; L, large; M, medium; S, small; HDL, high-density lipoprotein; P, particle concentration; L, total lipids; C, cholesterol; CE, cholesteryl esters; FC, free cholesterol; PL, phospholipids; TG, triglycerides. For all measurements, units are mmol/L. Atherosclerosis 2017 266, 48-57DOI: (10.1016/j.atherosclerosis.2017.09.021) Copyright © 2017 Elsevier B.V. Terms and Conditions

Fig. 4 Lipoprotein particle concentration and metabolic measures in healthy children with normal-high LDL-C (red symbols, n = 28), and per 1 mmol/L increments in LDL-C in healthy children (blue symbols, n = 57), compared with healthy children with normal-low LDL-C (black line, n = 29). Estimates on the right side of the zero-line indicate higher level in healthy children with normal-high LDL-C and increments in LDL-C, whereas estimates on the left side of the zero-line indicate lower level in healthy children with normal-high LDL-C and increments in LDL-C. Associations (beta coefficients) are log-transformed and SD-scaled, and adjusted for age and gender. Error bars represent 95% confidence intervals (95% CI). Abbreviations and units as in Fig. 1. Atherosclerosis 2017 266, 48-57DOI: (10.1016/j.atherosclerosis.2017.09.021) Copyright © 2017 Elsevier B.V. Terms and Conditions

Fig. 5 Lipoprotein particle concentration and metabolic measures in non-statin treated FH children, separated by mutation type (red symbols = LDL receptor negative mutations (Null alleles), n = 11; blue symbols = Other mutations, n = 15), compared with healthy children (black line, n = 57). Estimates on the right side of the zero-line indicate higher level in FH children, whereas estimates on the left side of the zero-line indicate lower level in FH. Associations (beta coefficients) are log-transformed and SD-scaled, and adjusted for age only. Error bars represent 95% confidence intervals (95% CI). Abbreviations and units as in Fig. 1. Atherosclerosis 2017 266, 48-57DOI: (10.1016/j.atherosclerosis.2017.09.021) Copyright © 2017 Elsevier B.V. Terms and Conditions

Atherosclerosis 2017 266, 48-57DOI: (10. 1016/j. atherosclerosis. 2017 Copyright © 2017 Elsevier B.V. Terms and Conditions